Hyperactive cancer cell glucose metabolism and nuclear DNA

The term 'hyperactive cancer cell glucose metabolism and nuclear DNA' refers to a composite of two distinct but interrelated hallmarks of cancer: metabolic reprogramming and genomic instability. Hyperactive glucose metabolism, often called the Warburg effect, involves a shift toward aerobic glycolysis to support the rapid energy and biosynthetic demands of malignant cells (Liberti & Locasale, 2016). Nuclear DNA represents the genetic repository that is often targeted by chemotherapy to induce apoptosis through DNA damage or replication stress (Helleday et al., 2008). This entry does not describe a single protein or receptor but rather a broad physiological state and a cellular organelle component. Consequently, it is not a valid canonical target name for drug discovery, which typically requires specific molecular entities like enzymes (e.g., Hexokinase 2) or DNA-binding proteins (Vander Heiden et al., 2009). Targeting these processes simultaneously is a common strategy in oncology, but they are treated as separate pharmacological targets.

Other names

Warburg effect and genomic DNACancer metabolic reprogramming and nuclear genomeAerobic glycolysis and nuclear DNA

Inhibition of glycolytic enzymes (e.g., Hexokinase) to deplete energy/precursors and induction of DNA damage (e.g., cross-linking or strand breaks) to trigger apoptosis.